European Commission approves Actemra/RoActemra by Roche to treat severe COVID-19
Approval based on results from four phase-III studies in motre than 5,500 patients
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Pfizer Covid vaccine provides partial protection against Omicron: Study
The yet-to-be peer-reviewed study, posted on the pre-print repository medRxiv recently, also found that considerable immunity is…
Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East
Under the terms of this agreement, Tabuk Pharmaceuticals will hold the marketing authorisation for select speciality products of…
Alembic Pharmaceuticals receives US FDA tentative approval for Selexipag tablets
The tablets are therapeutically equivalent to Uptravi tablets of Actelion Pharmaceuticals
Government brings action plan to standardise AYUSH products and their manufacturing process: Sonowal
The prime mandate of the commission is to publish and revise Ayurvedic Pharmacopoeia of India, Siddha Pharmacopoeia of India,…
NMPB and CSIR-CIMAP Lucknow sign MoU to promote medicinal plants
The MoU will facilitate development of QPM of medicinal plants and herbs identified by NMPB and help in the establishment of their…
SPARC licenses development and commercialisation rights of PDP-716 and SDN-037 to Visiox Pharma
SPARC to receive equity in Visiox along with other financial considerations
BDR Pharmaceuticals launches India’s first generic Midostaurin (MSTARIN) to treat Leukemia
The drug will be available in the strength of 25 mg
KAISHA Packaging achieves record of supplying seals for two billion doses of COVID vaccines globally…
The seal is used as closures for injection vials during the vaccination drive, and, is an essential part of the vaccine package…
How pharma companies can avoid cyber threats
Jagdish Mahapatra, VP, Asia, CrowdStrike, explains the need for pharmaceutical businesses to be equipped with the tools, education…